LUSPATERCEPT
Tracking # 20-819337
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LUSPATERCEPT IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES, PRIMARY MYELOFIBROSIS, AND BETA-THALASSEMIA. IT IS A RECOMBINANT FUSION PROTEIN THAT BINDS TRANSFORMING GROWTH FACTOR-BETA LIGANDS TO REDUCE SMAD2 AND SMAD3 SIGNALING. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTIONS, AND CONTRAINDICATIONS FOR LUSPATERCEPT AS A VALUABLE AGENT IN THE MANAGEMENT WHEN APPLICABLE FOR MEMBERS OF THE INTERPROFESSIONAL TEAM.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General